ATE342716T1 - Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel - Google Patents

Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel

Info

Publication number
ATE342716T1
ATE342716T1 AT00985264T AT00985264T ATE342716T1 AT E342716 T1 ATE342716 T1 AT E342716T1 AT 00985264 T AT00985264 T AT 00985264T AT 00985264 T AT00985264 T AT 00985264T AT E342716 T1 ATE342716 T1 AT E342716T1
Authority
AT
Austria
Prior art keywords
acetoxyphenyl
chloro
methyl
ethylammonium chloride
inflammatory agents
Prior art date
Application number
AT00985264T
Other languages
English (en)
Inventor
Bosscher Karolien De
Berghe Wim Vanden
Guy Haegeman
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of ATE342716T1 publication Critical patent/ATE342716T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00985264T 1999-12-21 2000-12-21 Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel ATE342716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204433 1999-12-21

Publications (1)

Publication Number Publication Date
ATE342716T1 true ATE342716T1 (de) 2006-11-15

Family

ID=8241039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985264T ATE342716T1 (de) 1999-12-21 2000-12-21 Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel

Country Status (8)

Country Link
US (1) US7053120B2 (de)
EP (1) EP1239850B1 (de)
AT (1) ATE342716T1 (de)
AU (1) AU2173101A (de)
CA (1) CA2395119A1 (de)
DE (1) DE60031439T2 (de)
ES (1) ES2274814T3 (de)
WO (1) WO2001045693A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239850B1 (de) 1999-12-21 2006-10-18 Universiteit Gent Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
GB0505509D0 (en) * 2005-03-17 2005-04-27 Ic Innovations Ltd Compounds
GB0526123D0 (en) * 2005-12-22 2006-02-01 Univ Gent Synephrine derivatives useful as anti-inflammatory agents
CA2651423A1 (en) * 2006-03-23 2007-10-04 The Regents Of The University Of Michigan Compositions and methods for generating transgenic animals
US20090235373A1 (en) * 2007-02-08 2009-09-17 The Regents Of The University Of Michigan Method of delivery of nucleic acids to a developing embryo
US20090156672A1 (en) * 2007-12-17 2009-06-18 Northwestern University Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities
WO2009092796A1 (en) * 2008-01-23 2009-07-30 Universiteit Gent Synephrine derivatives for the treatment of cancer
WO2011154413A1 (en) 2010-06-07 2011-12-15 Fritz-Lipmann-Insitut E. V. Leibniz-Institut Für Altersforschung Agent against glucocorticoid-induced osteoporosis
KR101567633B1 (ko) * 2013-07-03 2015-11-10 바이오스펙트럼 주식회사 감귤 미성숙과 추출물, 또는 시네프린 또는 이의 염을 유효성분으로 포함하는 염증성 피부질환 치료 또는 예방용 조성물
KR102704942B1 (ko) * 2019-01-11 2024-09-09 주식회사 엘지생활건강 Compound A를 유효성분으로 포함하는 피부 상태 개선용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600639A (en) * 1978-05-23 1981-10-21 Kali Chemie Pharma Gmbh Medicament preparation having resorption properties and method of producing the same
US4469689A (en) * 1983-03-30 1984-09-04 The Upjohn Company Sulfonate containing ester prodrugs of corticosteroids
US5086039A (en) * 1988-06-09 1992-02-04 Allelix Biopharmaceuticals, Inc. Pharmaceutical compositions and use thereof in treating inflammation
JPH0232016A (ja) * 1988-07-22 1990-02-01 Tsumura & Co Ｓｒｓ−ａ遊離抑制剤
DE4335523A1 (de) * 1993-10-19 1995-04-20 Ruetgerswerke Ag Antiallergikum
US5911988A (en) * 1995-04-28 1999-06-15 Bayer Corporation Method for treating asthma using SCF antibody
EP0885008B1 (de) * 1996-09-30 2009-12-30 Dennis Jones Regulation von Körpergewicht durch Materialien basierend auf Zitrusvariationen
EP1239850B1 (de) 1999-12-21 2006-10-18 Universiteit Gent Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel

Also Published As

Publication number Publication date
CA2395119A1 (en) 2001-06-21
US7053120B2 (en) 2006-05-30
ES2274814T3 (es) 2007-06-01
US20030055030A1 (en) 2003-03-20
WO2001045693A1 (en) 2001-06-28
EP1239850A1 (de) 2002-09-18
DE60031439D1 (de) 2006-11-30
DE60031439T2 (de) 2007-09-13
EP1239850B1 (de) 2006-10-18
AU2173101A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
DE60045508D1 (de) Dalda-analoge und ihre verwendung
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
SE9604786D0 (sv) New compounds
ATE212351T1 (de) Androsten-derivate
ATE364605T1 (de) 3-aryloxy und 3-heteroaryloxy substituierte benzo(b) thiophene als therapeutische wirkstoffe mit pi3k aktivität
SE9802208D0 (sv) Novel compounds
ATE342716T1 (de) Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
HUP0400553A2 (hu) Gyógyászati készítmények
ATE365735T1 (de) Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel
SE0102440D0 (sv) New compound
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
EE04551B1 (et) Optiliselt aktiivne pridl-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
SE9504662D0 (sv) New compounds
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
TR199900013T2 (xx) Yeni bile�ikler.
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
TR199901385T2 (xx) Piperidin t�revleri.
EA200101157A1 (ru) 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
HUP0402645A2 (hu) Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties